- Home
- SKYX vs KYTX Comparison
SKYX vs KYTX Comparison
Compare SKYX & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYX
- KYTX
- Stock Information
- Founded
- SKYX 2004
- KYTX 2018
- Country
- SKYX United States
- KYTX United States
- Employees
- SKYX N/A
- KYTX N/A
- Industry
- SKYX Building Products
- KYTX
- Sector
- SKYX Consumer Discretionary
- KYTX
- Exchange
- SKYX Nasdaq
- KYTX NYSE
- Market Cap
- SKYX 121.0M
- KYTX 125.2M
- IPO Year
- SKYX 2022
- KYTX 2024
- Fundamental
- Price
- SKYX $1.08
- KYTX $1.97
- Analyst Decision
- SKYX Strong Buy
- KYTX Buy
- Analyst Count
- SKYX 3
- KYTX 5
- Target Price
- SKYX $4.00
- KYTX $18.80
- AVG Volume (30 Days)
- SKYX 426.8K
- KYTX 308.2K
- Earning Date
- SKYX 05-13-2025
- KYTX 05-13-2025
- Dividend Yield
- SKYX N/A
- KYTX N/A
- EPS Growth
- SKYX N/A
- KYTX N/A
- EPS
- SKYX N/A
- KYTX N/A
- Revenue
- SKYX $86,276,876.00
- KYTX N/A
- Revenue This Year
- SKYX $28.10
- KYTX N/A
- Revenue Next Year
- SKYX $24.57
- KYTX N/A
- P/E Ratio
- SKYX N/A
- KYTX N/A
- Revenue Growth
- SKYX 46.77
- KYTX N/A
- 52 Week Low
- SKYX $0.72
- KYTX $1.88
- 52 Week High
- SKYX $2.14
- KYTX $24.91
- Technical
- Relative Strength Index (RSI)
- SKYX 36.97
- KYTX 34.02
- Support Level
- SKYX $1.15
- KYTX $1.88
- Resistance Level
- SKYX $1.23
- KYTX $2.16
- Average True Range (ATR)
- SKYX 0.12
- KYTX 0.19
- MACD
- SKYX -0.00
- KYTX -0.02
- Stochastic Oscillator
- SKYX 7.50
- KYTX 12.16
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. The company's technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post and is capable of feeding electric power to an appliance. The Company generates its income from the United States.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.